CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Fractional / Pixel CO2 Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03063684
NCT03063684N/ACompleted

Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

Hadassah Medical Organization·interventional·Posted Feb 24, 2017·Updated Aug 6, 2019

In Brief

A clinical study evaluating Fractional / Pixel CO2 Laser for Vaginal Atrophy and Lichen Sclerosus. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The study will examine the effects of fractional/pixel CO2 laser treatment in vaginal atrophy and in vulvar lichen sclerosus by means of histological and immuno-histochemical characterization of the epithelial layers and markers of tissue aging. The tissue characterization will be performed by biopsies of the vaginal or vulvar tissue at three different points of time: prior to treatment, two weeks after the third and last treatment, and one year after the last treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 24, 2017
Enrollment StartSep 1, 2017
Primary CompletionDec 30, 2018
Study CompletionApr 28, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.4 years ago

Interventions

Fractional / Pixel CO2 Laserdevice

The laser energy is transferred in a fractioned manner: the laser beam splits while passing through a lens to 81 dots (9 x 9 pixels) onto approximately 1 cm2, so the laser rays hit the tissue in small spots. For gynecological applications, the treatment is performed by a transducer, which was specifically designed for vaginal application.